DNA pol γ2 Inhibitors

Chemical inhibitors of DNA pol γ2 operate through various mechanisms to disrupt its role in mitochondrial DNA replication. Aphidicolin, a tetracyclic diterpene antibiotic, exerts its inhibitory effect on DNA pol γ2 by directly targeting the polymerase activity, thereby hampering the replication process essential for mitochondrial DNA maintenance. Similarly, nucleoside analogs like ddC (Zalcitabine), ddI (Didanosine), ddT (Stavudine), and 2',3'-Dideoxyadenosine interfere with DNA synthesis by incorporating themselves into the growing DNA strand. Once integrated, these analogs induce chain termination because they lack the 3' hydroxyl group necessary for forming the phosphodiester bond with the next nucleotide. Foscarnet, a pyrophosphate analog, inhibits DNA pol γ2 by binding to the enzyme's pyrophosphate binding site, which is crucial for the cleavage of pyrophosphate from the nucleotide triphosphate during DNA strand elongation.

Other inhibitors such as Edoxudine and the ribonucleotide exploit the fidelity of DNA pol γ2 to inhibit mitochondrial DNA synthesis. Edoxudine is incorporated into DNA due to its resemblance to thymidine but disrupts normal base-pairing, leading to dysfunctional DNA synthesis. Acyclovir, Ganciclovir, and Cidofovir are additional guanine or cytosine analogs that, once phosphorylated, are incorporated into the DNA, leading to premature termination of DNA replication. Cidofovir, in particular, does not require phosphorylation to become active, allowing it to readily incorporate into DNA and terminate the replication process. These chemicals target the core functions of DNA pol γ2, utilizing the enzyme's own substrate preferences and replication mechanisms to inhibit its activity and disrupt mitochondrial DNA replication.